1. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial
- Author
-
Segar, Matthew W, Patel, Kershaw V, Vaduganathan, Muthiah, Caughey, Melissa C, Butler, Javed, Fonarow, Gregg C, Grodin, Justin L, McGuire, Darren K, and Pandey, Ambarish
- Subjects
Heart Disease ,Prevention ,Diabetes ,Clinical Research ,Cardiovascular ,Metabolic and endocrine ,Aged ,Blood Glucose ,Diabetes Mellitus ,Type 2 ,Diabetic Angiopathies ,Female ,Follow-Up Studies ,Glycated Hemoglobin ,Glycemic Control ,Heart Failure ,Humans ,Incidence ,Male ,Middle Aged ,Retrospective Studies ,Risk Factors ,Time Factors - Abstract
ObjectiveTo evaluate the associations between long-term change and variability in glycemia with risk of heart failure (HF) among patients with type 2 diabetes mellitus (T2DM).Research design and methodsAmong participants with T2DM enrolled in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, variability in HbA1c was assessed from stabilization of HbA1c following enrollment (8 months) to 3 years of follow-up as follows: average successive variability (ASV) (average absolute difference between successive values), coefficient of variation (SD/mean), and SD. Participants with HF at baseline or within 3 years of enrollment were excluded. Adjusted Cox models were used to evaluate the association of percent change (from baseline to 3 years of follow-up) and variability in HbA1c over the first 3 years of enrollment and subsequent risk of HF.ResultsThe study included 8,576 patients. Over a median follow-up of 6.4 years from the end of variability measurements at year 3, 388 patients had an incident HF hospitalization. Substantial changes in HbA1c were significantly associated with higher risk of HF (hazard ratio [HR] for ≥10% decrease 1.32 [95% CI 1.08-1.75] and for ≥10% increase 1.55 [1.19-2.04]; reference
- Published
- 2020